Evexia Fast are tablets for dogs formulated to promote well-being and maintenance of joint function, especially in subjects subjected to physical effort, sporting activity or who have motor difficulties due to age or pathological conditions. The practical formulation in tablets of 2 g each, with a total weight of 60 g per pack, allows for easy daily administration, offering an effective, safe and pleasant solution even for the most wary animals. The tablets are palatable, as they can be administered either directly into the mouth or mixed with food, thus encouraging spontaneous acceptance by the dog. Regular integration of Evexia Fast helps support the vitality, resistance and movement capacity of four-legged friends, consequently improving their quality of life.
Therapeutic Indications
Evexia Fast is specifically indicated for dogs that need intensive joint support, both in situations of prolonged mechanical stress, such as during sporting activity and training, and in cases of painful and inflammatory conditions, such as osteoarthritis, hip dysplasia, osteoarthritis or chronic joint stiffness. The product can also be used as an adjuvant in post-operative treatments and during periods of motor rehabilitation, helping to restore normal joint function and simultaneously reducing pain. The tablets are particularly suitable for animals of advanced age, genetically predisposed to joint problems or with a sedentary lifestyle that favors the loss of muscle mass and flexibility. Regular supplementation helps preserve the ability to move, counteract inflammation and promote faster recovery after trauma or orthopedic surgery.
Composition
Each Evexia Fast tablet contains a synergistic blend of natural ingredients and active substances aimed at promoting joint health. The formulation makes use of glucosamine sulphate, chondroitin sulphate, methylsulfonylmethane (MSM), hydrolysed collagen and plant extracts including Devil's Claw, known for its anti-inflammatory and pain-relieving properties. The formula is completed by omega-3 fatty acids from fish oil, vitamin E with antioxidant action, manganese and zinc to support cartilage regeneration. The combination of these components promotes the nourishment of the cartilage, improves the lubrication of the joints, reduces degenerative processes and strengthens the ability to respond to microtraumas and inflammation, preserving joint functionality over time. The components are selected for their high bioavailability, ensuring maximum effectiveness thanks to rapid and constant absorption.
Contraindications
Evexia Fast must not be administered to dogs with known hypersensitivity or allergy to one or more components of the formulation, in particular to marine proteins, plant extracts such as Devil's Claw or MSM derivatives. Do not administer to animals suffering from serious liver or kidney disease, unless under strict veterinary supervision. The use in pregnant or lactating subjects should be evaluated by the veterinary surgeon to exclude possible adverse effects. In cases of animals undergoing anticoagulant therapies or using other joint supplements, it is advisable to always consult the veterinarian before continuing with the administration of Evexia Fast. In some rare cases, administration may cause mild gastrointestinal disorders such as nausea or diarrhea, which generally resolve spontaneously upon discontinuation of treatment.
Safety of the drug for the species
Evexia Fast was developed considering the safety of use in dogs of all breeds and ages. Its components are selected for their high tolerability profile and are dosed so as not to cause significant side effects, if used as indicated. The active ingredients do not interfere with main pharmacological treatments, however, in case of concomitant use with anti-inflammatory medicines, corticosteroids or drugs for chronic diseases, veterinary supervision is recommended to avoid potential overlaps. In safety studies conducted on adult and elderly dogs, no clinical, hematological or biochemical alterations attributable to supplementation with Evexia Fast were reported, even for prolonged periods. Safety is also guaranteed by the absence of ingredients of toxic origin and by the exclusive use of substances with proven efficacy and safety of use in the veterinary field.
Precautions
Keep Evexia Fast out of reach of children and pets not intended for treatment. Store the tablets in the original packaging, away from sources of heat, humidity and direct light. In case of accidental intake of doses exceeding the daily requirement, it is recommended to contact the veterinarian immediately, especially in the case of small animals or those particularly sensitive to the components of the product. Always wash your hands thoroughly after handling the tablets. To avoid intolerance phenomena, it is suggested to start treatment with half a dosage in the most sensitive subjects, evaluating their tolerance in the first few days. Do not use the product after the expiry date indicated on the packaging, even if apparently intact.
Method of administration
Evexia Fast tablets are designed to be simple to administer thanks to their palatability and small size. They can be offered directly into the mouth or mixed into the usual meal, adapting the method to the dog's preferences. It is recommended to administer the daily dose preferably on a full stomach, to facilitate the absorption of the active ingredients and avoid gastric disorders in the most sensitive subjects. In case of prolonged treatment or for specific needs, the dose can be divided into two administrations per day, thus ensuring constant maintenance of the levels of the active ingredients in the blood. Detailed instructions for the correct dosage depending on the dog's weight are shown on the package and we recommend following them scrupulously to obtain the best results. In the case of elderly or severely debilitated animals, adjust the dose based on the instructions of the treating veterinarian.
Treatment program
To obtain optimal effects on joint well-being, we recommend daily administration of Evexia Fast for at least 30 consecutive days, extending the treatment in the colder months, in phases of intense physical activity or in the presence of chronic joint pathologies. The duration of the program can be adapted based on the veterinary evaluation, who will be able to recommend cyclical or continuous treatment plans depending on the needs of the individual animal. In the case of sporting dogs or those subjected to intense mechanical effort, it is preferable to start administration a few days before the planned activity and continue during the recovery period. For chronic forms, the treatment can be repeated regularly with short breaks, while in maintenance periods, administration every other day can be considered to constantly support the health of the joints without exceeding the dosages.
Target species
Dogs
